BNTX
BioNTech SECompany with tickers: BNTX
CIK
1776985
CUSIP
09075V102
Shares Outstanding
252,884,261
Website
https://biontech.de/
13F Activity (30d)
8 filings
5 filers
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding BNTX
120 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| Dodge & Cox International Stock Fund | — | 2,517,713 | $223,774,331 | 0.37% | Long | 2026-03-31 | |
| T. Rowe Price Capital Appreciation Fund | — | 2,272,437 | $201,974,201 | 0.31% | Long | 2026-03-31 | |
| Fidelity Contrafund | — | 2,039,853 | $181,302,135 | 0.11% | Long | 2026-03-31 | |
| T. Rowe Price Mid-Cap Growth Fund, Inc. | — | 1,019,300 | $90,595,384 | 0.40% | Long | 2026-03-31 | |
| First Trust NYSE Arca Biotechnology Index Fund | — | 807,711 | $71,789,354 | 3.16% | Long | 2026-03-31 | |
| Fidelity Growth Company Fund | — | 570,401 | $62,875,302 | 0.08% | Long | 2026-02-28 | |
| iShares Biotechnology ETF | — | 599,506 | $53,284,093 | 0.66% | Long | 2026-03-31 | |
| Dodge & Cox Global Stock Fund | — | 525,778 | $46,731,149 | 0.39% | Long | 2026-03-31 | |
| MFS Mid Cap Value Fund | — | 492,991 | $43,817,040 | 0.27% | Long | 2026-03-31 | |
| JNL/T. Rowe Price Capital Appreciation Fund | — | 482,340 | $42,870,379 | 0.31% | Long | 2026-03-31 | |
| Fidelity Contrafund K6 | — | 444,604 | $39,516,404 | 0.12% | Long | 2026-03-31 | |
| Select Health Care Portfolio | — | 280,000 | $30,864,400 | 0.50% | Long | 2026-02-28 | |
| T. Rowe Price Capital Appreciation Equity ETF | — | 282,533 | $25,111,533 | 0.40% | Long | 2026-03-31 | |
| Schwab Fundamental International Equity ETF | — | 211,270 | $23,288,292 | 0.10% | Long | 2026-02-28 | |
| VY(R) T. ROWE PRICE CAPITAL APPRECIATION PORTFOLIO | — | 227,361 | $20,207,846 | 0.31% | Long | 2026-03-31 | |
| Fidelity Growth Company K6 Fund | — | 170,287 | $18,770,736 | 0.08% | Long | 2026-02-28 | |
| Fidelity Series Growth Company Fund | — | 148,302 | $16,347,329 | 0.08% | Long | 2026-02-28 | |
| Strategic Advisers Fidelity U.S. Total Stock Fund | — | 145,000 | $15,983,350 | 0.01% | Long | 2026-02-28 | |
| Strategic Advisers Fidelity Emerging Markets Fund | — | 141,200 | $15,564,476 | 0.04% | Long | 2026-02-28 | |
| JNL/T. Rowe Price Mid-Cap Growth Fund | — | 173,400 | $15,411,792 | 0.38% | Long | 2026-03-31 | |
| Penn Series Flexibly Managed Fund | — | 166,696 | $14,815,940 | 0.32% | Long | 2026-03-31 | |
| Select Pharmaceuticals Portfolio | — | 132,653 | $14,622,340 | 0.96% | Long | 2026-02-28 | |
| Fidelity New Millennium Fund | — | 121,600 | $13,403,968 | 0.25% | Long | 2026-02-28 | |
| ARK Genomic Revolution ETF | — | 126,929 | $13,130,805 | 1.06% | Long | 2026-04-30 | |
| Nomura International Core Equity Fund | — | 137,896 | $12,256,196 | 1.01% | Long | 2026-03-31 | |
| Victory Pioneer International Equity Fund | — | 105,431 | $11,621,659 | 0.64% | Long | 2026-02-28 | |
| T. Rowe Price Institutional Mid-Cap Equity Growth Fund | — | 124,500 | $11,065,560 | 0.40% | Long | 2026-03-31 | |
| Franklin International Growth Fund | — | 106,400 | $11,007,080 | 1.73% | Long | 2026-04-30 | |
| Select Biotechnology Portfolio | — | 85,400 | $9,413,642 | 0.18% | Long | 2026-02-28 | |
| International Equity Portfolio | — | 99,000 | $8,799,120 | 0.38% | Long | 2026-03-31 | |
| State Street(R) SPDR(R) Portfolio Developed World ex-US ETF | — | 96,445 | $8,572,051 | 0.02% | Long | 2026-03-31 | |
| MassMutual Mid Cap Growth Fund | — | 95,800 | $8,514,704 | 0.31% | Long | 2026-03-31 | |
| VIP Mid Cap Portfolio | — | 94,000 | $8,354,720 | 0.10% | Long | 2026-03-31 | |
| VanEck Biotech ETF | — | 90,077 | $8,006,044 | 2.15% | Long | 2026-03-31 | |
| Fidelity Balanced Fund | — | 72,001 | $7,936,670 | 0.01% | Long | 2026-02-28 | |
| Empower T. Rowe Price Mid Cap Growth Fund | — | 87,270 | $7,756,558 | 0.41% | Long | 2026-03-31 | |
| Franklin Biotechnology Discovery Fund | — | 73,400 | $7,593,230 | 0.73% | Long | 2026-04-30 | |
| Baillie Gifford International Alpha Fund | — | 82,416 | $7,325,134 | 0.39% | Long | 2026-03-31 | |
| Fidelity U.S. Equity Central Fund | — | 80,000 | $7,110,400 | 0.03% | Long | 2026-03-31 | |
| Nomura VIP International Core Equity Series | — | 76,770 | $6,823,318 | 1.02% | Long | 2026-03-31 | |
| Fidelity Nasdaq Composite Index Fund | — | 60,160 | $6,631,437 | 0.03% | Long | 2026-02-28 | |
| JNL/MFS Mid Cap Value Fund | — | 57,426 | $5,104,023 | 0.28% | Long | 2026-03-31 | |
| Invesco NASDAQ Next Gen 100 ETF | — | 45,059 | $4,966,854 | 0.55% | Long | 2026-02-28 | |
| Baillie Gifford International Stock Portfolio | — | 54,018 | $4,801,120 | 0.39% | Long | 2026-03-31 | |
| Strategic Advisers Emerging Markets Fund | — | 42,200 | $4,651,706 | 0.03% | Long | 2026-02-28 | |
| BlackRock Health Sciences Opportunities Portfolio | — | 41,921 | $4,620,952 | 0.07% | Long | 2026-02-27 | |
| Large-Cap Growth Portfolio | — | 50,628 | $4,499,817 | 0.37% | Long | 2026-03-31 | |
| T. Rowe Price Mid Cap Growth Portfolio | — | 47,320 | $4,205,802 | 0.40% | Long | 2026-03-31 | |
| Victory Pioneer Global Equity Fund | — | 34,597 | $3,813,627 | 0.48% | Long | 2026-02-28 | |
| JNL/T. Rowe Price Capital Appreciation Equity Fund | — | 41,544 | $3,692,431 | 0.41% | Long | 2026-03-31 |
Showing 1–50 of 120 positions